Global EditionASIA 中文雙語Fran?ais
    World
    Home / World / Middle East

    Chinese shots turn tide in Middle East

    By JAN YUMUL in Hong Kong | China Daily | Updated: 2021-03-11 10:29
    Share
    Share - WeChat
    A booth displaying a coronavirus vaccine candidate from China National Pharmaceutical Group (Sinopharm), is seen at the 2020 China International Fair for Trade in Services (CIFTIS), following the COVID-19 outbreak, in Beijing, in this September 4, 2020 file photo. [Photo/Agencies]

    Shipments of vital jabs across region fuel optimism for return to normalcy

    China's COVID-19 vaccines have come a long way in the Middle East. They were the first of the global offerings to secure authorization for emergency use there and one of them led a poll as the vaccine of choice in the region. To top that off, they have scored high on efficacy ratings.

    An online survey by data analytics firm YouGov has indicated that over 80 percent of those vaccinated against the coronavirus in the United Arab Emirates had opted for a Chinese-developed vaccine from Sinopharm.

    In the survey commissioned by G42 Healthcare, a subsidiary of Abu Dhabi-based technology company Group 42, 76 percent of the respondents said they believe the COVID-19 vaccines will bring life back to normal within a year.

    The UAE approved the Sinopharm shots on Dec 9, after declaring an 86 percent efficacy rate for the jabs.

    The YouGov-G42 survey, which started in January, was carried out to determine people's attitudes to COVID-19 vaccines. It found that safety and efficacy were the main factors that influenced their decisions.

    A total of 1,011 people were polled in the UAE for the survey, with the participants expressing optimism that the vaccines will help turn the tide in the public health crisis.

    The Abu Dhabi-based English daily The National reported on Tuesday that some people in the UAE who did not develop antibodies against COVID-19 could take a booster shot or a third dose of the Sinopharm vaccine, which is available for free across the country.

    High efficacy proved

    Chinese vaccines could find even more takers in the region in the coming months after Turkish researchers announced last week that a COVID-19 vaccine developed by China's Sinovac Biotech had an efficacy of 83.5 percent, based on phase III trials.

    The results unveiled by Ankara's Hacettepe University came after trials involving 10,216 participants aged 18-59.

    The UAE vaccine survey revealed that safety remained the top determinant for people considering vaccination, with 52 percent of respondents citing safety and efficacy as the key motivators. This was followed by perceptions of a lack of major side effects, at 50 percent, on a list of factors.

    Arab League Assistant Secretary-General Hossam Zaki, who received a batch of Sinopharm's COVID-19 vaccines in Cairo last week, said China's medical assistance to the Pan-Arab body "will effectively enhance the anti-epidemic capabilities of the Arab world", the Xinhua News Agency reported.

    Michael Stanat, vice-president of global operations at SIS International Research, a consulting firm headquartered in New York, said: "Chinese vaccines position China as a global healthcare leader and innovator alongside the likes of the US and Europe."

    For Martin Lush, global vice-president at NSF International, a US-based public health and safety organization, said the global elimination of the virus will not happen and that we "must learn to live with it, just like we do (with) flu".

    As of Monday, the UAE had administered 6,287,751 doses of COVID-19 vaccines, with a distribution rate of 63.57 doses per 100 people.

    The UAE's National Emergency Crisis and Disaster Management Authority noted on Feb 23 that authorities had noticed a gradual decrease in registered COVID-19 cases.

    "We confirm the effectiveness and safety of the vaccines that were approved in the country," it said.

    Most Viewed in 24 Hours
    Top
    BACK TO THE TOP
    English
    Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
    License for publishing multimedia online 0108263

    Registration Number: 130349
    FOLLOW US
    人妻中文久久久久| 无码国产伦一区二区三区视频| 无码AV片在线观看免费| 久久中文字幕精品| 免费无码毛片一区二区APP| 中文字幕无码不卡在线| 无码日韩人妻AV一区免费l | 国色天香中文字幕在线视频| 欧洲精品久久久av无码电影| 最近中文2019字幕第二页| 久久久久久综合一区中文字幕| 精品无码专区亚洲| 精品少妇人妻av无码久久| 亚洲精品无码久久一线| 久久久中文字幕日本| 精品人妻无码专区中文字幕| 久久AV高清无码| 亚洲性无码一区二区三区| 中文字幕亚洲无线码a| 91天日语中文字幕在线观看 | 亚洲中文字幕无码一区二区三区| 精品无码人妻一区二区三区| 无码无套少妇毛多18PXXXX | 无码国产福利av私拍| 国产成人无码精品久久久性色| 亚洲精品一级无码中文字幕| 最近高清中文字幕免费| 一本一道AV无码中文字幕| 中文字幕日韩精品无码内射| A最近中文在线| 人妻精品久久久久中文字幕69| 一本大道无码日韩精品影视| 中文字幕无码久久人妻| 亚洲AV无码乱码在线观看性色扶| 无码任你躁久久久久久| 亚洲一级Av无码毛片久久精品| 中文字幕无码日韩专区免费| 日韩av无码中文字幕| 最近免费中文字幕高清大全 | 亚洲一日韩欧美中文字幕欧美日韩在线精品一区二 | 台湾佬中文娱乐中文|